Guidelines for Reporting Outcomes in Trial Reports

This report, the Consolidated Standards of Reporting Trials (CONSORT)–Outcomes 2022 extension, is a consensus statement on the standards for reporting outcomes

Related Keywords

United States ,Canada ,Toronto ,Ontario ,London ,City Of ,United Kingdom ,Vermont ,America ,Canadian ,Pharma Gmb ,Robin Hayeems ,James Webbe ,Eli Lilly ,Petros Pechlivanoglou ,Lisa Stallwood ,Mss Saeed ,Andrea Chiaramida ,Amgen ,Peter Gilgan Centre For Research ,American College Of Rheumatology ,Cundill Centre For Child ,Analysis Methods Group ,Pfizer ,Astrazeneca ,Health Sciences ,Forest Pharmaceuticals ,Vertex Pharmaceuticals ,Takeda Pharmaceutical Co Ltd ,Drug Administration ,Sickkids Foundation ,School Of Public Health ,Canadian Institutes Of Health Research ,Key Development Phases ,Laboratory Tests Along With Reliability ,Parexel International ,Genentech ,Mental Health ,Novartis ,Transparency Of Health Research ,Canadian Cancer Society ,Research Manitoba ,Td Bank Financial Group ,Imperial College London ,Centre For Addiction ,Children Hospital Research Institute Of Manitoba ,Bristol Myers Squibb ,University Of Vermont ,Larner College Of Medicine ,Regeneron Pharmaceuticals ,Reformulary Group ,Savient Pharmaceuticals ,Division Of Neonatal ,European League ,Health Research ,Consolidated Standards ,Reporting Trials ,Cochrane Methodology Register ,Reporting Planned Endpoints ,Clinical Trials ,Standard Protocol Items ,Interventional Trials ,Development Phases ,Section Ref ,Terms Used ,Checklist Items ,Outcomes Used ,Primary Outcome ,Specific Measurement Variable ,Systolic Blood Pressure ,Analysis Metric ,Change From Baseline ,Final Value ,Time Point ,Each Outcome ,Minimal Important Change ,Outcome Data Were Continuous ,Were Analyzed ,Cutoff Values Used ,Outcome Assessments Were Performed ,Several Time Points After Randomization ,Time Points Used ,Composite Outcome Was Used ,Individual Components ,Composite Outcome ,Outcomes That Were ,Trial Registry ,Trial Protocol ,Study Instruments Used ,Laboratory Tests ,Along With Reliability ,Population Similar ,Study Sample ,Trial Specific Training Necessary ,Study Instruments ,Wechsler Abbreviated Scale ,Processes Used ,Duplicate Measurements ,After Data Collection ,Range Checks ,Outcome Data Values ,Checklist Item ,Sample Size ,Target Difference Between Treatment Groups ,Minimal Important Difference ,Difference Elicitation ,Statistical Methods ,Methods Used ,Secondary Outcomes ,Coprimary Outcomes ,Same Outcome Assessed ,Multiple Time Points ,Subgroup Analyses ,Outcome Data From ,Report That ,Outcome Data Were Excluded ,Assess Patterns ,Handle Missing Outcome Items ,Entire Assessments ,Outcome Analysis Population Relating ,Randomized Analysis ,Prespecified Outcome Analyses ,Estate Where ,Results Can Be Found ,Ancillary Analyses ,There Were ,Analyses That Were ,They Were Performed ,North America ,Peter Gilgan Centre ,Sick Children ,Interest Disclosures ,Cundill Centre ,Youth Depression ,Canadian Institutes ,Hospital Research Institute ,Cochrane Prospective Meta Analysis Methods ,Hoffmann La Roche ,Horizon Therapeutics ,American College ,Treating Anxiety Disorders ,Young Children ,Financial Group ,Drs Butcher ,Executive Deputy Editor ,Cochrane Neonatal ,Neonatal Perinatal Medicine ,Larner College ,Chris Gale ,Neonatal Medicine ,Public Health ,Open Science Framework ,